MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-16-2026
Spectrum Pharmaceuticals Depreciation & Amortization 2011-2026 | SPPI
Annual Depreciation & Amortization Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 248 K | 286 K | 261 K | 1.62 M | 28.4 M | 28 M | 26.5 M | 31.9 M | 25.4 M | 22.1 M | 12.2 M | 5.65 M | 4.51 M | 4.24 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.9 M | 248 K | 13.7 M |
Quarterly Depreciation & Amortization Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 K | - | 200 K | 147 K | 73 K | - | 212 K | 138 K | 65 K | - | -105 K | 282 K | 140 K | - | 1.49 M | 1.4 M | 1.33 M | - | 21 M | 14 M | 7 M | - | 21 M | 14 M | 6.98 M | - | 19.5 M | 12.5 M | 6.01 M | - | 21.2 M | 14.1 M | 7.02 M | - | 18.7 M | 12.2 M | 5.98 M | - | 16.2 M | 6.62 M | 3.27 M | - | 6.71 M | 4.04 M | 1.67 M | - | 3.99 M | 2.48 M | 1.15 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.2 M | -105 K | 6.83 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Happiness Biotech Group Limited
HAPP
|
380 K | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
1.3 M | $ 1.72 | 4.57 % | $ 201 M | USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
3.38 M | $ 31.9 | 3.39 % | $ 2.12 B | USA |
 |
AstraZeneca PLC
AZN
|
5.73 B | - | - | $ 96.9 B |  Britain |
 |
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | USA |
 |
Compugen Ltd.
CGEN
|
475 K | $ 2.68 | 0.75 % | $ 250 M |  Israel |
 |
Galera Therapeutics
GRTX
|
20 K | - | -32.59 % | $ 7.61 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
332 K | $ 0.75 | 9.37 % | $ 34.3 M | Israel |
 |
Esperion Therapeutics
ESPR
|
105 K | $ 3.13 | 0.32 % | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
4.04 M | $ 31.76 | 1.5 % | $ 855 M | USA |
|
Forte Biosciences
FBRX
|
64 K | $ 22.94 | 4.54 % | $ 297 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | USA |
 |
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
4.93 M | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | Israel |
 |
Hutchison China MediTech Limited
HCM
|
13.3 M | $ 11.93 | 1.53 % | $ 10.2 B | China |
 |
Cyclacel Pharmaceuticals
CYCCP
|
5 K | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
1.74 M | - | - | $ 384 M | Britain |
 |
Heron Therapeutics
HRTX
|
2.31 M | $ 0.92 | 3.78 % | $ 153 M | USA |
 |
Gracell Biotechnologies
GRCL
|
58.8 M | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
5.37 M | $ 14.69 | -1.36 % | $ 211 M | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.42 | -0.73 % | $ 5.63 M | Israel |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |